167 related articles for article (PubMed ID: 15068836)
21. Tumoral cell mtDNA approximately 8.9 kb deletion is more common than other deletions in gastric cancer.
Kamalidehghan B; Houshmand M; Panahi MS; Abbaszadegan MR; Ismail P; Shiroudi MB
Arch Med Res; 2006 Oct; 37(7):848-53. PubMed ID: 16971224
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN
Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite changes in nipple aspirate fluid and breast tissue from women with breast carcinoma or its precursors.
Zhu W; Qin W; Ehya H; Lininger J; Sauter E
Clin Cancer Res; 2003 Aug; 9(8):3029-33. PubMed ID: 12912952
[TBL] [Abstract][Full Text] [Related]
24. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
[TBL] [Abstract][Full Text] [Related]
25. High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer.
Ellsworth RE; Ellsworth DL; Lubert SM; Hooke J; Somiari RI; Shriver CD
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):915-9. PubMed ID: 14504204
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity and microsatellite instability at RAD52 and RAD54 loci in breast cancer.
Nowacka-Zawisza M; Bryś M; Hanna RM; Zadrozny M; Kulig A; Krajewska WM
Pol J Pathol; 2006; 57(2):83-9. PubMed ID: 17019970
[TBL] [Abstract][Full Text] [Related]
27. mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations.
Vega A; Salas A; Gamborino E; Sobrido MJ; Macaulay V; Carracedo A
Oncogene; 2004 Feb; 23(6):1314-20. PubMed ID: 14647457
[TBL] [Abstract][Full Text] [Related]
28. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
29. Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.
Oudin C; Bonnetain F; Boidot R; Végran F; Soubeyrand MS; Arnould L; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2007 May; 30(5):1145-51. PubMed ID: 17390016
[TBL] [Abstract][Full Text] [Related]
30. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
[TBL] [Abstract][Full Text] [Related]
31. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer?
Losanoff JE; Zhu W; Qin W; Mannello F; Sauter ER
Breast; 2008 Oct; 17(5):540-2. PubMed ID: 18571924
[TBL] [Abstract][Full Text] [Related]
32. Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers.
Hienonen T; Sammalkorpi H; Enholm S; Alhopuro P; Barber TD; Lehtonen R; Nupponen NN; Lehtonen H; Salovaara R; Mecklin JP; Järvinen H; Koistinen R; Arango D; Launonen V; Vogelstein B; Karhu A; Aaltonen LA
Cancer Res; 2005 Jun; 65(11):4607-13. PubMed ID: 15930278
[TBL] [Abstract][Full Text] [Related]
33. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
[TBL] [Abstract][Full Text] [Related]
34. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer.
Wu CW; Yin PH; Hung WY; Li AF; Li SH; Chi CW; Wei YH; Lee HC
Genes Chromosomes Cancer; 2005 Sep; 44(1):19-28. PubMed ID: 15892105
[TBL] [Abstract][Full Text] [Related]
36. Detection of mitochondrial DNA mutations in gestational trophoblastic disease.
Chiu PM; Liu VW; Ngan HY; Khoo US; Cheung AN
Hum Mutat; 2003 Aug; 22(2):177. PubMed ID: 12872261
[TBL] [Abstract][Full Text] [Related]
37. Analysis of potential cancer biomarkers in mitochondrial DNA.
Jakupciak JP; Dakubo GD; Maragh S; Parr RL
Curr Opin Mol Ther; 2006 Dec; 8(6):500-6. PubMed ID: 17243485
[TBL] [Abstract][Full Text] [Related]
38. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization.
Vauhkonen H; Vauhkonen M; Sajantila A; Sipponen P; Knuutila S
Cancer Genet Cytogenet; 2006 Jun; 167(2):150-4. PubMed ID: 16737915
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
[TBL] [Abstract][Full Text] [Related]
40. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates.
Parrella P; Xiao Y; Fliss M; Sanchez-Cespedes M; Mazzarelli P; Rinaldi M; Nicol T; Gabrielson E; Cuomo C; Cohen D; Pandit S; Spencer M; Rabitti C; Fazio VM; Sidransky D
Cancer Res; 2001 Oct; 61(20):7623-6. PubMed ID: 11606403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
